DEVELOPMENT OF MEMORY-ENHANCING AGENTS IN THE TREATMENT OF ALZHEIMERS-DISEASE

被引：1

作者：

ABERNETHY, DR

机构：

来源：

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY | 1987年 / 35卷 / 10期

关键词：

D O I：

10.1111/j.1532-5415.1987.tb02298.x

中图分类号：

R592 [老年病学]; C [社会科学总论];

学科分类号：

03 ; 0303 ; 100203 ;

摘要：

引用

页码：957 / 958

页数：2

共 14 条

[1] MUSCARINIC AGONIST THERAPY OF ALZHEIMERS-DISEASE - A CLINICAL-TRIAL OF RS-86 [J].

BRUNO, G ;

MOHR, E ;

GILLESPIE, M ;

FEDIO, P ;

CHASE, TN .

ARCHIVES OF NEUROLOGY, 1986, 43 (07) :659-661

[2] RESEARCH IN NURSING-HOMES - ETHICAL ISSUES [J].

CASSEL, CK .

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1985, 33 (11) :795-799

[3] PHYSOSTIGMINE AND ARECOLINE - EFFECTS OF INTRAVENOUS INFUSIONS IN ALZHEIMER PRESENILE-DEMENTIA [J].

CHRISTIE, JE ;

SHERING, A ;

FERGUSON, J ;

GLEN, AIM .

BRITISH JOURNAL OF PSYCHIATRY, 1981, 138 (JAN) :46-50

[4] ALZHEIMERS-DISEASE - A DISORDER OF CORTICAL CHOLINERGIC INNERVATION [J].

COYLE, JT ;

PRICE, DL ;

DELONG, MR .

SCIENCE, 1983, 219 (4589) :1184-1190

[5] REDUCED DOPAMINE-BETA-HYDROXYLASE ACTIVITY IN ALZHEIMERS-DISEASE [J].

CROSS, AJ ;

CROW, TJ ;

PERRY, EK ;

PERRY, RH ;

BLESSED, G ;

TOMLINSON, BE .

BRITISH MEDICAL JOURNAL, 1981, 282 (6258) :93-94

[6] REDUCED SOMATOSTATIN-LIKE IMMUNOREACTIVITY IN CEREBRAL-CORTEX FROM CASES OF ALZHEIMER-DISEASE AND ALZHEIMER SENILE DEMENTIA [J].

DAVIES, P ;

KATZMAN, R ;

TERRY, RD .

NATURE, 1980, 288 (5788) :279-280

[7]

DAVIES P, 1976, LANCET, V2, P1403

[8]

DAVIS KL, 1982, AM J PSYCHIAT, V139, P1421

[9] CHOLINERGIC DRUGS IN ALZHEIMERS-DISEASE [J].

DAVIS, KL ;

MOHS, RC .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (20) :1286-1287

[10]

MOHS RC, 1985, AM J PSYCHIAT, V142, P28

← 1 2 →